BRCA2 mutations substitute for wild type p53 in ovarian cancers with ZMIZ1 overexpression

Abstract

Peer reviewed

M. Decker, N. Nadkarni, T. Neff, L. Rogers, S. Park, D. Bender, A. Ahmed, K. DeGeest, A. Dupuy and M. Goodheart

Gynecologic oncology, Vol.127(1), pp.S20-S20

10/2012

DOI: 10.1016/j.ygyno.2012.07.055

View Online

Title: Subtitle: BRCA2 mutations substitute for wild type p53 in ovarian cancers with ZMIZ1 overexpression
Creators: M. Decker - Department of Obstetrics and Gynecology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA
N. Nadkarni - Department of Obstetrics and Gynecology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA
T. Neff - University of Iowa
L. Rogers - University of Iowa
S. Park - University of Iowa
D. Bender - University of Iowa
A. Ahmed - University of Iowa
K. DeGeest - University of Iowa
A. Dupuy - University of Iowa
M. Goodheart - University of Iowa
Resource Type: Abstract
Publication Details: Gynecologic oncology, Vol.127(1), pp.S20-S20
Publisher: Elsevier Inc
DOI: 10.1016/j.ygyno.2012.07.055
ISSN: 0090-8258
eISSN: 1095-6859
Language: English
Date published: 10/2012
Academic Unit: Obstetrics and Gynecology; Internal Medicine; Anatomy and Cell Biology; Pathology; Management and Entrepreneurship ; Holden Comprehensive Cancer Center
Record Identifier: 9984286261602771

5 Record Views